Carlumab (CNTO 888) 是一种具有高亲和力的人源化抗CCL2(趋化因子配体 2) 抗体。Carlumab 可用于癌症，尤其是前列腺癌的研究。
| 生物活性 | Carlumab (CNTO 888) is a humanised anti-CCL2(chemokine ligand 2) antibody with high affinity. Carlumab can be used incancerresearch, particularly in prostatecancer[1]. |
| IC50& Target | |
| Clinical Trial | |
| CAS 号 | |
| Sequence | B21505606百英货号，100 mg 15000元；张雪要求上线20220919 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com